샘플 요청 목록

 카트 문의
시장보고서
상품코드
1799134

헬스케어 CMO 시장

Healthcare CMO
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 174 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 헬스케어 CMO 시장은 2030년까지 2,911억 달러에 이를 전망

2024년에 1,587억 달러로 추정되는 헬스케어 CMO 세계 시장은 2024-2030년간 CAGR 10.6%로 성장하여 2030년에는 2,911억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 의약품 CMO는 CAGR 9.3%를 나타내고, 분석 기간 종료시에는 1,850억 달러에 이를 것으로 예측됩니다. 의료기기 CMO 부문의 성장률은 분석 기간중 CAGR13.2%로 추정됩니다.

미국 시장은 432억 달러로 추정, 중국은 CAGR 14.2%로 성장 예측

미국의 헬스케어 CMO 시장은 2024년에 432억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 592억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 14.2%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 7.8%와 9.3%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 8.3%를 보일 전망입니다.

세계의 헬스케어 CMO 시장 - 주요 동향과 촉진요인 정리

위탁생산 기관이 헬스케어 공급망에 필수적인 이유는 무엇일까?

헬스케어 위탁생산기관(CMO)은 의약품, 의료기기, 생물학적 제제의 제조 서비스를 아웃소싱하고 있습니다. 이들 조직은 제형화, 제조에서 포장, 유통에 이르기까지 복잡한 업무를 담당하고 있습니다. 헬스케어 기업들이 비용 절감, 시장 출시 시간 단축, 규제 준수에 대한 압박에 직면하면서 CMO는 생산 전략에서 점점 더 중심적인 역할을 하고 있습니다.

CMO는 헬스케어 브랜드 소유주가 자본 집약적인 인프라 투자 없이도 전문 시설과 기술 전문지식을 활용할 수 있습니다. 이는 틈새 치료법이나 의료 기술을 개발하는 중소기업에게 특히 가치가 있습니다. 대기업들도 CMO를 활용하여 제조의 유연성을 높이고, 수요 급증에 대응하고, 현지 생산 능력으로 새로운 시장에 진출하고 있습니다.

CMO는 제약 및 의료 기술 분야에서 어떻게 역량을 확장하고 있는가?

의약품 CMO는 고역가 의약품 제조, 무균 주사제, 연속 생산 능력을 강화하고 있습니다. 단클론 항체 및 세포 치료제를 포함한 생물학적 제제 제조에서는 업스트림 및 다운스트림 처리 능력에 많은 투자가 이루어지고 있습니다. CMO는 충전 및 마감 서비스, 콜드체인 물류, 섬세한 제제를 위한 고급 패키징을 확장하고 있습니다.

의료기기 분야에서 CMO는 정밀 금형, 적층 성형, 자동화를 도입하여 외과 기기, 진단 기기, 웨어러블 기기의 까다로운 요구 사항을 충족합니다. 전자 부품 통합, 멸균 서비스, 품질 문서화 등은 국제 규제 프레임워크를 준수하기 위해 확장되고 있는 중요한 역량입니다. 많은 CMO들은 현재 설계 지원부터 규제 당국 신청, 시판 후 지원까지 엔드 투 엔드 서비스를 제공하고 있으며, 제품 수명주기 관리에서 CMO의 역할을 강화하고 있습니다.

CMO에 대한 수요가 증가하는 곳은 어디이며, 어떤 치료 분야가 아웃소싱 활동을 주도하고 있는가?

CMO 서비스에 대한 수요는 북미, 유럽, 아시아태평양에서 증가하고 있지만, 서비스의 전문성이나 중점 치료 분야는 지역별로 차이가 있습니다. 암, 자가면역질환, 희귀질환은 복잡한 제조 니즈와 표적치료모델로 인해 의약품 아웃소싱을 촉진하는 주요 분야입니다. 의료기기 분야에서는 진단, 최소침습수술, 커넥티드 헬스 솔루션에 대한 수요가 가장 높습니다.

자체 인프라가 부족한 생명공학 기업들은 임상시험 물질과 상업적 규모의 생산 모두에서 CMO에 대한 의존도가 높아지고 있습니다. 기존 제약사들은 사내 자원을 최적화하기 위해 성숙한 제품 라인을 저비용의 지역 CMO에 아웃소싱하고 있습니다. 진단 의약품 분야에서는 CMO가 세계 보건 수요에 대응하여 분석 키트, 시약, 기기 구성 요소의 신속한 스케일업을 지원하고 있습니다. 이러한 패턴은 임상 및 상업적 공급망 전반에 걸쳐 CMO의 관련성을 강화하고 있습니다.

헬스케어 CMO 시장의 성장 원동력은?

헬스케어 CMO 시장의 성장은 제조 전문화, 치료의 복잡성, 공급망 최적화와 관련된 몇 가지 요인으로 인해 발생합니다. 생물학적 제제, 무균주사제, 개인맞춤형 의약품의 개발 증가는 전문 인프라를 갖춘 수탁 제조업체의 이용을 촉진하고 있습니다. 자동화, 컴플라이언스 시스템, 고처리량 생산의 발전은 업무 효율성과 규제 준수성을 향상시키고 있습니다. 또한, 수익성이 낮은 레거시 제품의 아웃소싱 증가, 가상 바이오 기업의 진입, 세계 제약 파이프라인의 확장도 성장을 뒷받침하고 있습니다. 헬스케어 기업들이 보다 간소화된 운영과 기술적 스케일업을 추구함에 따라 CMO는 의약품과 의료기기에 걸쳐 중요한 생산 파트너가 되고 있습니다.

부문

유형(의약품 CMO, 의료기기 CMO)

조사 대상 기업 예

  • Almac Group
  • AMRI(Albany Molecular Research Inc.)
  • Boehringer Ingelheim BioXcellence
  • Catalent, Inc.
  • CordenPharma International GmbH
  • Emergent BioSolutions Inc.
  • Famar Health Care Services
  • Fareva Group
  • Grifols International S.A.
  • Jubilant Pharmova Ltd.
  • Lonza Group AG
  • Patheon(by Thermo Fisher Scientific)
  • PCI Pharma Services
  • Pfizer CentreOne
  • Piramal Pharma Solutions
  • Recipharm AB
  • Samsung Biologics
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.09.03

Global Healthcare CMO Market to Reach US$291.1 Billion by 2030

The global market for Healthcare CMO estimated at US$158.7 Billion in the year 2024, is expected to reach US$291.1 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Pharmaceutical CMO, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$185.0 Billion by the end of the analysis period. Growth in the Medical Device CMO segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$43.2 Billion While China is Forecast to Grow at 14.2% CAGR

The Healthcare CMO market in the U.S. is estimated at US$43.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$59.2 Billion by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Healthcare CMO Market - Key Trends & Drivers Summarized

Why Are Contract Manufacturing Organizations Becoming Integral to Healthcare Supply Chains?

Healthcare Contract Manufacturing Organizations (CMOs) provide outsourced manufacturing services for pharmaceutical products, medical devices, and biologics. These organizations handle complex tasks ranging from formulation and production to packaging and distribution. As healthcare companies face pressure to reduce costs, accelerate time-to-market, and maintain regulatory compliance, CMOs are playing an increasingly central role in production strategies.

CMOs offer access to specialized facilities and technical expertise without requiring capital-intensive infrastructure investments by the healthcare brand owner. This is particularly valuable for small and mid-sized firms developing niche therapies or medical technologies. Larger companies are also leveraging CMOs to increase manufacturing flexibility, manage demand surges, and enter new markets with local production capabilities.

How Are CMOs Expanding Capabilities Across Pharmaceuticals and Medtech?

Pharmaceutical CMOs are enhancing capabilities in high-potency drug production, sterile injectables, and continuous manufacturing. Biologics manufacturing, including monoclonal antibodies and cell therapies, is seeing significant investment in upstream and downstream processing capacity. CMOs are expanding fill-finish services, cold chain logistics, and advanced packaging for sensitive formulations.

In the medical device sector, CMOs are incorporating precision tooling, additive manufacturing, and automation to meet the stringent requirements of surgical, diagnostic, and wearable devices. Electronic component integration, sterilization services, and quality documentation are critical capabilities being scaled up for compliance with international regulatory frameworks. Many CMOs now offer end-to-end services from design assistance to regulatory submissions and post-market support, consolidating their role in product lifecycle management.

Where Is CMO Demand Rising and Which Therapeutic Areas Lead Outsourcing Activity?

Demand for CMO services is rising in North America, Europe, and Asia-Pacific, with regional differences in service specialization and therapeutic focus. Oncology, autoimmune diseases, and rare conditions are key areas driving pharmaceutical outsourcing due to complex manufacturing needs and targeted treatment models. For medical devices, demand is strongest in diagnostics, minimally invasive surgery, and connected health solutions.

Biotech firms with limited in-house infrastructure are increasingly relying on CMOs for both clinical trial materials and commercial-scale production. Established pharma companies are outsourcing mature product lines to CMOs in lower-cost regions to optimize internal resources. In diagnostics, CMOs are supporting rapid scaling of assay kits, reagents, and instrument components in response to global health demands. These patterns are reinforcing CMO relevance across clinical and commercial supply chains.

What Is Driving Growth in the Healthcare CMO Market?

Growth in the healthcare CMO market is driven by several factors related to manufacturing specialization, therapeutic complexity, and supply chain optimization. Rising development of biologics, sterile injectables, and personalized medicines is encouraging use of contract manufacturers with specialized infrastructure. Advances in automation, compliance systems, and high-throughput production are improving operational efficiency and regulatory alignment. Growth is also supported by increased outsourcing of low-margin legacy products, entry of virtual biotech companies, and expansion of global pharmaceutical pipelines. As healthcare firms seek leaner operations and technical scale-up, CMOs are becoming critical production partners across drugs and devices.

SCOPE OF STUDY:

The report analyzes the Healthcare CMO market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Pharmaceutical CMO, Medical Device CMO)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Almac Group
  • AMRI (Albany Molecular Research Inc.)
  • Boehringer Ingelheim BioXcellence
  • Catalent, Inc.
  • CordenPharma International GmbH
  • Emergent BioSolutions Inc.
  • Famar Health Care Services
  • Fareva Group
  • Grifols International S.A.
  • Jubilant Pharmova Ltd.
  • Lonza Group AG
  • Patheon (by Thermo Fisher Scientific)
  • PCI Pharma Services
  • Pfizer CentreOne
  • Piramal Pharma Solutions
  • Recipharm AB
  • Samsung Biologics
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Healthcare CMO - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Outsourced Pharmaceutical and Medical Device Manufacturing Drives Growth in Healthcare CMOs
    • Surge in Biologics and Complex Drug Formulations Spurs Demand for Specialized CMO Capabilities in Aseptic and High-Potency Manufacturing
    • Expansion of Small and Virtual Biotech Companies Strengthens Business Case for End-to-End CMO Partnerships
    • Growing Regulatory Complexity Across Global Markets Encourages Reliance on CMOs With Compliance and QA Expertise
    • Increased Focus on Cost Optimization and Time-to-Market Pressures Propel Demand for Flexible, Scalable CMO Services
    • Expanding CDMO (Contract Development and Manufacturing Organization) Models Combine R&D With Scalable Production
    • Growth in Personalized Medicine and Orphan Drug Development Generates Opportunities for Niche and Adaptive CMOs
    • Rising Demand for Fill-Finish, Packaging, and Serialization Services Strengthens CMO Role in Final Drug Product Delivery
    • Technological Advancements in Continuous Manufacturing and PAT Tools Enhance Efficiency and Traceability in CMO Processes
    • Rising Adoption of Subscription-Based and Pay-Per-Use Models Makes Fitness Clubs More Accessible to Price-Sensitive Consumers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Healthcare CMO Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Healthcare CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceutical CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceutical CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Pharmaceutical CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Device CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Medical Device CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Medical Device CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • JAPAN
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • CHINA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: China 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • EUROPE
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Healthcare CMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • FRANCE
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: France 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • GERMANY
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Healthcare CMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • INDIA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: India 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Healthcare CMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Healthcare CMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • AFRICA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제